TP53 and amyotrophic lateral sclerosis: These studies [24,224,380,439,441] support the concept of an aberrant re-emergence of an atypical PCD mechanism, involving p53 activation and redistributions of mitochondrial cell death proteins, participating in the pathogenesis of motor neuron degeneration in human ALS.